Cognitive tests for psychiatry

Impact: Economic impacts, Health impacts


Cognitive biomarkers are of considerable interest in psychiatry and to those developing treatments (pharmacological or psychological). We have developed a set of tests of affective functions which me be of particular relevance to functional outcomes in mental health. 4 tests have been licensed to Cambridge Cognition Lts. 12 tests are under ongoing review pending further results.

Category of impact

  • Economic impacts
  • Health impacts
2016 - 2018